Study of AT-587 in Healthy Subjects
NCT07728487 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 62
Last updated 2026-07-27
Summary
This study will assess the safety, tolerability and pharmacokinetics (PK) of AT-587 in healthy subjects
Conditions
- Hepatitis E
Interventions
- DRUG
-
AT-587
Parallel Assignment
- OTHER
-
Placebo
Parallel Assignment
Sponsors & Collaborators
-
Atea Pharmaceuticals, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-07-13
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071
NCT00409929 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety and Tolerability, Pharmacokinetics, Food-effect and Pharmacodynamics of EHP-101 in Healthy Volunteers
NCT03745001 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Single Doses of SBT115301 in Healthy Participants
NCT05388981 ·Status: COMPLETED ·Phase: PHASE1
-
A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects
NCT05569941 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-Human Safety Trial of MTX-474
NCT06535841 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants
NCT07110610 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Pharmacokinetics, Safety, and Tolerability of Atumelnant in Healthy Japanese and Caucasian Participants
NCT07221084 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects
NCT00953888 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of SHR8735 in Healthy Subjects
NCT04701216 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants
NCT03285620 ·Status: COMPLETED ·Phase: PHASE1
-
AT-301 Nasal Spray in Healthy Adults
NCT04519788 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects
NCT02873156 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly Participants
NCT05745207 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects
NCT00416546 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers
NCT03023787 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety, Tolerability and Pharmacokinetics (PK) (Including Food Effect) of Oral Doses of AZD5847 in Healthy Volunteers
NCT01037725 ·Status: COMPLETED ·Phase: PHASE1
-
AZD5985 Single Ascending Dose Study
NCT00967356 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men
NCT03400488 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2082 in Healthy Male Subjects
NCT03402178 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJM347 in Healthy Male Caucasian and Japanese Subjects in the Fasted and Fed State
NCT03133468 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers
NCT00754715 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of EQU-001 in Healthy Volunteers
NCT05004571 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy Volunteers
NCT04238364 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers
NCT00829127 ·Status: WITHDRAWN ·Phase: PHASE1
-
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects
NCT01818869 ·Status: COMPLETED ·Phase: PHASE1